Suchergebnisse - "Eryilmaz, Isil Ezgi"

PubPharm (21)

1

Association between the apoptotic effect of Cabazitaxel and its pro-oxidant efficacy on the redox adaptation mechanisms in prostate cancer cells with different resistance phenotypes

enthalten in: Cancer biology & therapy | 2024

von Eryilmaz, I. | Egeli, U. | Cecener, G.

2

The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort

enthalten in: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer | 2024

von Eryilmaz, I. | Vuruskan, B. | Kaygisiz, O. | +3

3

The regulatory effect of cabazitaxel on epithelial-mesenchymal transition in metastatic prostate cancer

enthalten in: Journal of cancer research and therapeutics | 2023

von Eryilmaz, I. | Eskiler, G. | Egeli, U. | +1

4

An in vitro redox adaptation model for metastatic prostate cancer : Establishing, characterizing and Cabazitaxel response evaluating

enthalten in: Clinical and experimental pharmacology & physiology | 2022

von Eryilmaz, I. | Egeli, U. | Cecener, G.

5

The Anticancer Effect of Inula viscosa Methanol Extract by miRNAs' Re-regulation : An in vitro Study on Human Malignant Melanoma Cells

enthalten in: Nutrition and cancer | 2022

von Colak, D. | Egeli, U. | Eryilmaz, I. | +4

6

An in vitro redox adaptation model for metastatic prostate cancer : Establishing, characterizing and Cabazitaxel response evaluating

enthalten in: Clinical and Experimental Pharmacology and Physiology | 2022

von Eryilmaz, I. | Egeli, U. | Cecener, G.

7

Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells

enthalten in: Human & experimental toxicology | 2021

von Guney Eskiler, G. | Ozkan, A. | Eryilmaz, I. | +2

8

Farklı direnç fenotiplerine sahip prostat kanseri hücre hatlarında apigenin ve fenetil izotiyosiyanat (PEITC) kombinasyonu ile oluşturulan prooksidan kanser terapi modeli etkinliğinin ve moleküler hedeflerinin araştırılması ; Investigation of efficiency and molecular targets of prooxidant cancer therapy model generated by combination of apigenin and phenethyl isothiocyanate (PEITC) in prostate cancer cell lines with different resistance phenotypes

Erschienen: Dissertation, Bursa Uludağ Üniversitesi, 2021

von Eryılmaz, I.

9

Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease

enthalten in: Clinical neurology and neurosurgery | 2020

von Eryilmaz, I. | Erer, S. | Zarifoglu, M. | +15

10

Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

enthalten in: Cancer genetics | 2020

von Cecener, G. | Sabour Takanlou, L. | Sabour Takanlou, M. | +12